Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-08T16:23:52.782Z Has data issue: false hasContentIssue false

The Role of Exceptionalism in the Evolution of Bioethical Regulation

Published online by Cambridge University Press:  08 June 2023

Sergei Shevchenko*
Affiliation:
Institute for Philosophy and Social Theory, Beograd, Srbija
Alexey Zhavoronkov
Affiliation:
Institut für Philosophie, Goethe-Universität Frankfurt, Frankfurt am Main, Deutschland
*
Corresponding author: Sergei Shevchenko; Email: simurg7891@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

The paper aims to present a critical analysis of the phenomenon and notion of exceptionalism in bioethics. The authors demonstrate that exceptionalism pertains to phenomena that are not (yet) entirely familiar to us and could potentially bear risks regarding their regulation. After an overview of the state of the art, we briefly describe the origins and evolution of the concept, compared to exception and exclusion. In the second step, they look at the overall development debates on genetic exceptionalism, compared to other bioethical debates on exceptionalism, before presenting a detailed analysis of a specific case of early regulation of genetic screening. In the last part, the authors explain the historical background behind the connection between exceptionalism and exclusion in these debates. Their main conclusion is that while the initial stage of the discussion is shaped by the concept of exceptionalism and awareness of risks of exclusion, the later development centers around exceptions that are needed in detailed regulatory procedures.

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press

Exceptionalism in Bioethics Debates: A Brief Overview

The notion of exceptionalism occupies a remarkable but somewhat uncertain position in bioethics. There are several ongoing debates on exceptionalism, including genetic exceptionalism, HIV exceptionalism, and neuro exceptionalism. Each is focused on a need for specific normative engagement with some new phenomenon or biomedical practice. The term itself usually emerges at a relatively late point when the already established exceptionally rigorous forms of regulation are directly criticized as obsolete. In other words, exceptionalism as a specific regulative approach exists before the explicit appearance of the corresponding term in bioethical debates.

The uniqueness of regulation is mainly justified through peculiar risks of social exclusion: due to hereditary features, HIV status, or behavioral traits essentialized in neuroscientific terms. The arguments favoring exceptionalism frequently involve dramatic plots—often of the kind that led to the Nuremberg Code. The code and the prevention of the revival of Nazi eugenics programs are the cornerstones of bioethics (pre)history. The institutionalization of bioethics is also linked to a series of negative events, where recollections of Nazi eugenics have usually accompanied the public discussion. The founding fathers of bioethics saw the condemnation of cancer cell experiments at the Jewish Chronic Disease Hospital (1962), the Henry K. Beecher study (1966), and the Tuskegee syphilis study (in the 1970s) as parts of the same story.Footnote 1 All phases of this history involved Nazi analogies. Such arguments highlighted that eugenic practices are compatible with modern liberal society, and the development of certain new biomedical technologies may bring their comeback closer.Footnote 2 Since general strategies to protect human rights did not work in these cases, such technologies required exceptional regulation.

The term “exceptionalism” frequently appears in academic texts about healthcare policy when authors intend to criticize superfluously restrictive regulation of a significant field. Even the early articles that headline the term speak of the “end of exceptionalism” – in relation to HIVFootnote 3 or genetics.Footnote 4 Alternatively, exceptionalism is often questioned,Footnote 5 as its use requires a systematic revision.Footnote 6 Nevertheless, there are also papers presenting general arguments in favor of exceptionalismFootnote 7 or describing individual cases demonstrating its validity,Footnote 8 mostly in an attempt to present sound counterarguments to those who criticize the notion.

Exceptionalism may be motivated inter alia by the peculiar scope of ethical problems or by the unknown side effects of a specific biomedical technology. The collision between individual bioethical principles often results in exceptional regulations. For instance, the tension between beneficence and nonmaleficence produces exceptions related to terminal sedation and relief of refractory pain in the legislation of countries that prohibit euthanasia.Footnote 9 In other cases, the conflict between the patient’s autonomy and the beneficence of their family members can lead to exceptions in privacy regulation, ultimately rethinking the foundational concept of autonomy.Footnote 10 There are also situations where a person can exercise autonomy through free and deliberate acceptance of the health risks but is not likely to benefit from the proposed intervention, because it is experimental and not designed to help the medical research subject.Footnote 11

Social issues can play a crucial role in exceptionalism, be it the problem of trust for research exceptionalism,Footnote 12 stigmatization and social exclusion in the case of genetic tests and HIV,Footnote 13 or job discrimination for neuro exceptionalism.Footnote 14 These social concerns initially evoke images of a severe social exclusion requiring exceptional regulation but afterward gradually evolve into a more nuanced system of regulatory exceptions.

There are also many cases when we can reasonably characterize the specific regulation of certain practices as exceptional, although the concept of exceptionalism does not make an explicit appearance in relevant documents. For instance, according to pre-2000 versions of the Declaration of Helsinki, nontherapeutic research was regulated specifically and with maximum strictness. It mainly referred to “healthy volunteer” research, and the exceptional strictness was related to the lack of direct benefit to the subject.Footnote 15 Robert Levine was the voice of physicians pushing for a more nuanced approach to the Declaration. He pointed out that medical research is a long and multistage process that typically includes both therapeutic and nontherapeutic interventions.Footnote 16 Therefore, distinguishing nontherapeutic research as an area of exceptional regulation did not correspond to the logic of the process. It was replaced by nuances in the regulation of specific procedures and the remaining exceptional regulation of all medical research. However, this specific regulation was much broader in coverage and not so rigorous.

The mentioned type of research exceptionalism is a subject of debate as well. Some of the arguments against it are based on the need for more rapid approval of research, for example, to find new antibiotics.Footnote 17 There have also been proposals to replace the rigorous research regulation with risk payment, as established for workplaces with comparable risks.Footnote 18 Recognizing the problem of public trust, scholars propose to pay exceptional attention to transparency in the allocation of risk-based payment.Footnote 19

In short, “exceptionalism” has frequently played a crucial role in bioethical regulations and related debates, at least since the 1960s. Unfortunately, there is still no theoretical framework that could be useful not only to understand the evolution of certain debates involving exceptionalism but also to provide aid in confronting the gap between the emergence of a new phenomenon or challenge and the formulation of detailed regulatory procedures. In what follows, we will develop this framework by outlining the boundaries and relations between the notions of exceptionalism, exception, and exclusion.

Theoretical Ramifications: Exceptionalism–Exception–Exclusion

The brief glimpse into various uses of the notion of exceptionalism in bioethics, which serves as an introduction to the closer analysis of a specific case of “genetic exceptionalism,” shows us that there is a necessity for a clear differentiation between “exceptionalism,” “exception,” and “exclusion.” This differentiation should serve as a methodological connection between several crucial debates, providing a clear orientation in answering the ever-present question of whether we (still) need the notions of exceptionalism and/or exception in our description of a particular case.

When dealing with a new (or not entirely familiar) phenomenon that we consider “exceptional,” we face the crucial question of what could go wrong. While trying to find out if the existing regulatory cases, standards, and procedures can be (at least partially) helpful in this situation, we also recall the worst cases that serve as a basis for the precautionary principle. This precautionary principle helps us gradually find the necessary instruments (including a variety of possible exceptions) we have to apply to avoid the risk of exclusion of new information and/or particular social groups to which this information pertains. In other words, “exceptionalism” primarily accompanies our analysis at an early stage, while “exception” plays a more prominent role later in time, as soon as we delve into the details of particular procedures. In turn, “exclusion” plays a vital role at both stages since it is needed to assess potential or actual negative scenarios. Before discussing the relations between the three notions in bioethical regulation, let us look at their origins and evolution.

Exceptionalism

From the perspective of Western philosophy, the origins of the notion of exceptionalism lie in the seventeenth- and eighteenth-century development of historical research (and of related sciences, such as geography and ethnology) due to a series of geographical discoveries and the growing interest in regions outside Europe. Most important in this regard are the debates between those who wanted to provide a general system of all new knowledge about foreign nations, races, and cultural traditions (while often trying to promote the idea that all European nations, or a particular European nation, were in some way superior to others) and those who insisted on their unique character which cannot and should not be made part of such system. This difference can be exemplified by the debates between Immanuel Kant and Johann Gottfried von Herder on the definition and goals of anthropology,Footnote 20 predating the early twentieth-century crisis and split of the discipline into philosophical and cultural anthropology. Kant’s anthropology was closely connected to his system of critical philosophy, particularly to his ethics with its categorical imperative. While this approach was advantageous for Kant’s practical philosophy (his political philosophy, in particular), it also had its downsides, as Kant used his ethical principles in controversial, discriminatory descriptions of human races during the 1770s and 1780s, which included a vertical classification according to their motives (Triebfeder) and capability to make rational decisions. Herder, on the contrary, challenged the necessity of using the concept of race, defending the idea of looking at each nation separately. While a very effective instrument in the debates against the misuse of the notion of race, this approach also had its weaknesses, as it was focused on the uniqueness of nations (and “national spirits”), defying any systematic attempts to drive essential conclusions from the similarities between them. Both Kant’s and Herder’s views on the phenomenon of exceptionalism, namely the discriminatory idea of European moral exceptionalism and the exceptionalist approach to each nation, significantly impacted the subsequent intellectual tradition.

Despite being a significant implicit part of the debates of the European Enlightenment, the notion has not made its explicit appearance in philosophical works until the nineteenth century. In the wake of the rise of national ideologies and movements across the world, “exceptionalism” found its way into the mainstream tradition of political philosophy, for instance, in the form of the concept of “American exceptionalism” that goes back to the works of Alexis de Tocqueville.Footnote 21 During the twentieth century and into the twenty-first century, the notion was and still is regularly used in theory of law, most notably in debates on “constitutional exceptionalism”Footnote 22 and “criminal law exceptionalism.”Footnote 23

In bioethics, the notion was adapted and modified to describe the initial situation of many debates, such as those on genetic information,Footnote 24 health policy,Footnote 25 HIV treatment, and neuroethical issues.Footnote 26 In this new role, “exceptionalism” defines the limitations of the existing methods, marking a new (still mostly uncharted) territory and deterring us from all too readily using old instruments instead of looking for new ones. It applies to a situation when it is impossible to slightly adjust a previous approach while further work is necessary to find a new working method. However, its usefulness becomes very limited as a new approach takes shape, as “exceptionalism” per se defies systematic analysis by questioning and undermining it at each step. After a systematic framework is set, “exceptionalism” does more harm than good, as it can confuse scholars and non-scholars alike, impeding them from reaching any clear, empirically relevant conclusion. In short, the notion of “exceptionalism” has its window of opportunity when confronting new phenomena as a core element of the precautionary principle. However, it can be counterproductive for later stages of research that systematize the theoretical findings and lead to practice-oriented conclusions. Contradictions between principles create the conditions for special regulation, but they are not always enough for exceptionalism. Such conflicts can create individual regulatory exceptions or urge exceptionalism at a particular stage of the field’s evolution.

Exception

The notion of exception has a much longer history which is more complex but also often overlooked by philosophers who tend to limit its genealogy primarily to Giorgio Agamben, Carl Schmitt, Søren Kierkegaard (as Schmitt’s source), and Walter Benjamin (as Agamben’s source).Footnote 27 We first encounter it in Cicero’s speech Pro Balbo, as part of his examination of the relations between rules and exceptions in Roman law. During the Middle Ages, the vast majority of cases of its use are commentaries to the famous Code of Justinian, which included a sophisticated classification of different types of exceptions that can deny the applicability of a claim in some instances.Footnote 28 During the period between the fifteenth and the seventeenth centuries, the notion played a significant role in theological arguments and disputes, but also in philosophical debates on natural law and regularities in nature (in works of Francis Bacon, Rudolf Goclenius, and Theodor Zwinger), before finally finding its way into Leibniz’s philosophy of law which integrated theological, legal, and philosophical questions into one systematic approach.Footnote 29 More than a century later, the notion was used in Kant’s ethics and philosophy of law.Footnote 30 Starting with Kant, “exception” gradually develops from a strictly legal notion to a broad concept of utmost importance for many sciences, from history and philosophy to sociology and political theory.Footnote 31 Part of this development is its implementation in twentieth-century bioethics.

Compared to more homogeneous “exceptionalism,” “exception” can be used in various ways. From the legal perspective, which still, since Antiquity, plays a dominant role in the use of the concept, some exceptions are included in rules, expanding them and making them more resilient in the face of challenges from new phenomena. Such is the case with clauses in laws that are meant to be a “safety mechanism” against a possible state of exception (which can quickly occur during crisis periods like the epidemic of coronavirus disease [COVID-19]). On the other hand, many exceptions cannot fit into existing theories or practices. In the latter case, given that we try to preventively define the boundaries of a rule or practice against all kinds of exceptions, “exception” (e.g., in collocations “with the exception of” and “except from/to”) can indicate that something is excluded from the rule or a particular practice.Footnote 32 However, such preventive measures only apply to a number of cases, as some occurrences—and discoveries—cannot be predicted. In the latter case, “exclusion,” sometimes coupled with “exceptionalism” as a signal to exert caution in dealing with the uncertain, can immediately tackle the problem. At the same time, “exceptionalism” is not an apt instrument for finding a long-term solution, as such a goal needs instruments of systematization.

If we look at exceptions from another angle, namely not before they take place but after they have already occurred, we can also differentiate between several kinds. There are, first, one-time exceptions that do not have lasting consequences apart from immediate ones in a concrete situation. Other exceptions can transform rules and mainstream practices. Finally, there are some hybrid cases where exceptions have a limited impact, not by changing fundamental tendencies but rather by making minor modifications to the treatment of specific range of cases that still fall under a general rule, thus playing a stabilizing role. As we will show in the specific example of the debate on genetic exceptionalism, there are cases with a whole set of different kinds of exceptions that can be used to make the mainstream practice more stable in the long term. Unlike “exceptionalism,” “exception” is much more versatile and is applicable to various stages of the development of specific theoretical approaches, debates, and practices. While individual exceptions may eventually become obsolete, the overall concept of exception always retains its usefulness in formulating and applying regulatory standards.

Exclusion

In comparison to the other two notions, the boundaries of the notion of exclusion are significantly vaguer. This is partly due to its historical closeness to “exception,” as the meanings of exception and exclusion were included in the semantical field of the Latin exceptio (cf. also the German Ausnahme). From the Late Middle Ages, the word was present in various legal studiesFootnote 33 and other texts but did not gain such theoretical significance as exception and exceptionalism. In the twentieth century, exclusion was part of several prominent concepts in various fields (from the “causal exclusion problem” in analytical philosophy to “social exclusion” in sociology, political theory, and psychology). In recent philosophical studies, the notion has, for instance, gained much presence in the debates on immigration.Footnote 34 In bioethical theories, for instance, in disability bioethics, “exclusion” is primarily used to describe the situation of certain groups that are or have been subjected to discrimination.Footnote 35

In light of the genealogy of the notion, it is not surprising that the idea of exclusion can often accompany the notion of exception, as they complement and explain each other. However, it is also essential to understand the differences between these two concepts—which are, unfortunately, often either overlooked by scholars from various fields or left without sufficient clarification, as the authors are primarily focused on the concept of the state of exception.Footnote 36 On the one hand, labeling something as exceptional means excluding it from all usual theoretical approaches in order to start our search for new methods and instruments. On the other hand, excluding something from our considerations does not necessarily mean including it in the field that is or will eventually be covered by another approach. Exclusion can also be a process of separation of something that is (with or without justification) deemed unnecessary or even harmful for the whole. Excluded elements (information, social groups, or something else) can remain marginal for a considerable time without good prospects of altering their status. In contrast to phenomena with “exceptional” status, they usually are not given special attention, as they are considered (or painted as) relatively unimportant. We assume that the forms of exclusion highlighted during the construction of a bioethical theory can shape exceptionalism and, consequently, the range of regulatory exceptions. However, the nature of this connection requires further research. In our subsequent analysis of the debates on genetic exceptionalism, we will emphasize the role of exclusion as the counterpart of inclusion, in the same sense it is used in sociology, anthropology, and disability studies.

As shown above, the notions of exceptionalism, exception, and exclusion are related to each other but have specific traits that should be appropriately recognized to use these terms at a proper time and place. In the next part, we will demonstrate how these notions can be applied to the analysis of the development of the debates on genetic exceptionalism.

Debates on Genetic Exceptionalism

Before examining one specific case, let us look at the overall development of the debates. In the early 1990s, the term “exceptionalism” began to appear in the debates on biomedicine regulation.Footnote 37 At that time, it referred to the AIDS epidemic; at the end of the decade, it began to deal with the prospects of genetic testing.Footnote 38 In the discussions at that time, ethical issues closely intertwined with questions about the legal status of HIV or gene-related information. These discussions tended to begin with applied regulatory issues, immediately involving historical examples of stigmatization and cases of personal data misuse.Footnote 39

HIV and genetic exceptionalism refer to the specific regulation of relevant medical tests and health information because of the distinctive risks of discrimination against patients or persons closely connected with them.Footnote 40 However, HIV and genetic exceptionalism differ in explicitness and contestability of the link between specific regulation and discrimination. The “HIV exceptionalism” label appeared “to distinguish the policies that had emerged in the face of the AIDS epidemic from more conventional approaches to public health issues.”Footnote 41 The AIDS epidemic put the public health community in a situation requiring unprecedented levels of medical testing. Since the deadly danger of the virus puts HIV-positive people at risk of highly distressing, pervasive exclusion, HIV or AIDS exceptionalism was about implementing necessary health policy, not about the perspectives of new biomedical fields and technologies, as in the case of genetic exceptionalism.

Neuro exceptionalism is sometimes called a third generation of exceptionalism. Arisen after HIV and genetic exceptionalism, it continues to highlight ethical concerns on privacy and identity. The paper comparing genetic and neurotechnologies in terms of these risks is one of the texts marking the birth of neuroethics as a special discipline.Footnote 42 Its authors, Judy Illes and Eric Racine, see parallels in the technical difficulty of discriminating between rare variables in genes or neuroimaging and those related to pathology. However, they attribute the ethical exceptionality of neuroimaging not to this complexity itself but to the fact that cultural presuppositions will interfere with the processing and interpretation of the neuroimages.

The article’s commentators agreed that the development of neurotechnology has provided additional practical relevance to philosophical questions about personal identity. However, they contested the need to separate neuroethics from bioethics, attacking the uniqueness of neuroimaging.Footnote 43 Footnote 44 In the next few years, Judy Illes, one of the paper’s authors and founders of neuroethics, paid more attention to the role of neuroimaging in overcoming the stigma of psychiatric patients than to the debates about the uniqueness of information generated by neurotechnologies.Footnote 45

The debates about generic exceptionalism were also mainly built around the question of the uniqueness of genetic information. All arguments in favor of this view have been dismissed. The Task Force on Genetic Information and Insurance pointed out back in 1993 that genetic information is not exclusive: 1) in terms of its importance to the patient’s future (there are other medical tests with comparable predictive power); 2) in terms of its importance to other family members (information about infectious diseases, for example, may have the comparable importance); and 3) in terms of the possible stigma associated with genetics (there are other, more apparent social fragmentation factors like race or gender).Footnote 46

In a later study, legal scholars Lawrence Gostin and James Hodge largely agreed with the conclusions of the Task Force. However, they highlighted the risks of nonmedical use of genetic information by employers, educational institutions, the police, and others.Footnote 47 Tom Murray supported these arguments against genetic exceptionalism, showing their bioethical relevance.Footnote 48 Michael Green and Jeffrey Botkin, while rejecting the special status of genetic information, recommended focusing on stigma, including the intrafamilial stigma associated with genetic information.Footnote 49 Despite reaching a relative consensus, debates about exceptionalism returned in the 2010s, already in the post-genomic era. Garrison et al. criticized the questioning of the uniqueness of genetic information.Footnote 50 By introducing the notion of genomic contextualism as a replacement for genetic exceptionalism, they proposed starting with the types of stigma and exclusion that could be associated with specific genomic tests. It implies that genetic testing is no longer a field of exceptional regulation. Some, but not all, tests, hereditary diagnoses, and counseling situations may be of great ethical concern. Therefore, specific — sufficiently rigorous — guidelines may be proposed for them.

Nowadays, genetic exceptionalism denotes a much less monolithic thing than HIV exceptionalism, be it on the level of theory or practical regulation. The term “genetic exceptionalism” is mainly used to indicate the vector of criticism. For example, it has recently been used to show that considerations of justice do not speak unequivocally against the use of genetic test results in insurance.Footnote 51 In many countries, life insurance is an area with an exclusive ban on the use of genetic data.Footnote 52 The arguments criticizing the total ban usually include some limited exceptions undermining rigorous regulation, which is considered to be related to genetic exceptionalism.

Despite the semantic blurring, we assume the presence of genetic exceptionalism not only as a field of debate but also as a rigorist approach to ethical regulation. When the debate about genetic exceptionalism began, this rigorism had already begun to override itself through a nuanced approach toward the issue of disclosing genetic information. This approach was embodied in increasingly precise ethical guidelines and in the unique role of genetic counselors who aim to prevent social exclusion and stigmatization.Footnote 53 In this light, the appeal to retire the notion is justified, not because “genetic exceptionalism” was not aptly used in the initial stages of the debates, but because it is no longer needed at the current stage, as the focus of current discussions shifts to individual exceptions and problems of exclusion.

The Case of Early Regulation of Genetic Screening

It would not be unreasonable to say that genetic exceptionalism began with the declaration of an emergency related to the genetic decline of the human population. Exceptionalism in the regulation of genetic tests was a response to this alarm. Invoking historical and theological arguments, it was directed against possible forms of exclusion of “defective” genomes. In the 1960s, Hermann Müller, a biologist who had previously been involved in (non-Nazi) eugenic research, publicly shared his “genetic pessimism” about the decline of biological heredity. Other scientists have criticized eugenics for its ineffectiveness and failure to prevent the degradation of the human gene pool.Footnote 54 Initially, the ethical arguments against this view were theologically colored. Paul Ramsey pointed out that the Christian understanding of responsibility is not about genetic control or preventing genetic deterioration, even when it occurs.Footnote 55 In May 1970, a small conference “Early Diagnosis of Human Genetic Defects: Scientific and Ethical Considerations” was convened. Hastings Center staff participated in a face-to-face discussion of the ethical challenges of genetic testing. Robert Morison, the conference’s chairman, emphasized negative historical examples of eugenic discrimination.Footnote 56

At that time, a group for genetic counseling was already working at the Hastings Center. It consisted of theologian James Gustafson and scientists Richard Roblin and Marc Lappé. Their article was one of the major early sources on the ethics of genetics. The text mentions possible forms of stigma and discrimination, proposes a specific set of principles for regulating the field, and outlines a move toward more nuanced regulation. In our view, this article contains a vision of genetic testing as a field of exceptional regulation. It can be considered illustrative of the role of social exclusion for exceptionalism and the future dissolution of exceptionalism into a set of more specific rules.

The article published in 1972 in The New England Journal of Medicine summarizes an agenda for developing ethical regulations of genetic screening.Footnote 57 The authors proposed an extended list of ethical principles for screening programs. Despite the accurate ethical regulation, the authors’ approach was not casuistic. The principles they propose apply to any genetic screening program, regardless of its scope, the diseases detected, or the technical tools used. They also identify a core ethical challenge and propose a program for dealing with it. Judging by the fact that there is “a flood tide of ill-considered programs in genetic screening,”Footnote 58 this program has been accepted by decisionmakers in the field.

First, the authors identified the reduction of the frequency of apparently deleterious genes as a both practically and morally unacceptable objective of genetic screening.Footnote 59 According to them, each significant screening program should be aimed at supporting the decisionmaking of a pregnant woman and improving the well-being of affected individuals while the affected community should guide the design and implementation of a significant program. At the same time, Lappé et al., referring to equal access to screening, specifically mention the two groups most affected by eugenics programs in Europe and the United States: Ashkenazi Jews and African Americans. They stress that the community involved in the screening program prevents the exclusion of individuals as potential carriers of apparently deleterious genes and ensures the program’s focus on improving the health of people who suffer from genetic disorders. At the same time, health policymakers make sure that particular communities are not excluded from a screening program.

The article concludes by outlining possible types of exclusions based on the sickle-cell traits identified by screening, the most frequent focus of genetic screening at that time. In that case, disclosure of genetic information may cause problems with life insurance for adults. Moreover, even confident knowledge about such risks may make parents unnecessarily restrict physical activity of the affected child.Footnote 60 This can be understood as an attempt to look into the future from 1972. The named risks of stigmatization may require special regulatory exemptions, even after genetic testing becomes a routine procedure.

We should note that the risks of stigmatization were not the product of the imagination of the bioethicists. Drs. Robert Murray and Michael Kaback, who shared their experiences with the Hastings Center research group, reported cases of employment discrimination against adult African Americans involved in the sickle-cell screening. Also, the majority of the programs targeted preschool children who could not benefit directly from the test results. These programs were tied to school admission and marriage licensing.Footnote 61

In the early stages of the debates on genetic screening, the complexity of possible exclusion made it necessary to treat genetic screening as an experimental practice since it involved “untried testing procedures” and was “vitally concerned with the acquisition of new knowledge.”Footnote 62 Hence, it required the highest degree of protection for human subjects provided by its regulation as a form of human experimentation, not a routine clinical procedure. Such regulation was the fencing tape, showing an area of probably severe but unknown risks. In this case, genetic exceptionalism was not based on judgments about the uniqueness of genetic information. Instead, the Hastings Center research group asserted exceptionalism as a temporary barrier preventing possible misuse of genetic information, exclusion, and stigma.

The movements from exclusion through exceptionalism to a set of exceptions can be seen as the swinging of the historical pendulum between more and less strict regulation. Nevertheless, historical examples of social exclusion, or their interpretations, are aggregated when formulating exceptionally rigorous regulations. Notions of specific forms of exceptionalism more often arise when the need for specific regulation of a particular area is called into question. Terms of HIV, genetic and neuro exceptionalism emerged to denote the object of criticism.

Several decades can pass between the emergence of exceptionalism as an approach to regulation and the introduction of the term in academic papers, as in the case of genetic exceptionalism, or it can happen almost simultaneously, as in the case of neuro exceptionalism.Footnote 63 Lappé et al. proposed specific ethical principles for genetic tests in the early 1970s while genetic exceptionalism became a subject of discussion only in the late 1990s, as shown in the previous section.

Regardless of this time lag, exceptionalism as an approach to regulation provides a site for understanding the social impact of new biomedical technologies. Once this work is done, exceptionalism begins to be called by its name, emerging as an object of criticism. After that, the strictness of regulation can be weakened without fear of being accused of insensitivity to social exclusion or discrimination.

Social Exclusion Shaping Regulatory Exceptionalism

The connection between genetic technologies and eugenics-driven exclusion is neither necessary nor obvious. It takes a considerable amount of work to construct historical arguments to make this connection an essential element of bioethical discussions. Silke Schicktanz et al. identified six types of historical arguments in bioethics (slippery slope-, analogy-, continuity-, knockout/taboo-, ethical progress-, and accomplice arguments).Footnote 64 In doing so, the arguments tend to draw from biomedical experiments implicating discrimination and exclusion, from Nazi eugenics to the Tuskegee syphilis study.

The current myth of the origins of bioethics partly explains the propensity for such eugenic parallels. Nevertheless, there is a controversy over why modern Germany rigidly regulates medical procedures, which are most often compared to eugenic practices. As we point out below, Nazi eugenics separated lives that were not worth living, so Preimplantation Genetic Diagnosis (PGD) here is strictly regulated today. In the Soviet Union, geneticists were repressed and excluded from the academy, so today, their colleagues can more openly claim free regulation of what is called “liberal eugenics.”

The rules guiding PGD in contemporary Germany are much stricter than in other European countries.Footnote 65 One explanation for this phenomenon is that the political elite here is more religious than the general public. However, the proponents of this explanation admit that strict PGD regulation is much more often linked to Germany’s Nazi past.Footnote 66 German public speakers have done definite semantic workFootnote 67 to associate Third Reich eugenics with the medical manipulation of embryos.Footnote 68 Concerns of a repetition of Nazi history have been assembled through reference to practices of exclusion having an unambiguous moral assessment. As Catherine Braun argues, a universalist and inclusive understanding of human dignity led to the exceptional regulation of reprogenetics in Germany.Footnote 69

The impossibility of excluding someone’s life as not worthy of being lived led to the prohibition of the instrumentalization of life. Thanks to this, the German regulation combines a woman’s right to abortion with rigorous PGD regulation. The German Stem Cell Act distinguishes between biological cell life and life endowed with human dignity. Ingrid Metzler regards this distinction as analogous to Agamben’s distinction between zoe and bios. Footnote 70 Thus, the forms of exclusion taken into account have also nuanced the repertoire of exceptions in German regulation. In contrast, Catholic bioethicists in Italy defended the sanctity of life, leading to restrictions on the right to abortion and the limitation of stem cell research.Footnote 71

In Nazi Germany, eugenic exclusion reached unprecedented size, the memory of which has resulted in contemporary reprogenetic exceptionalism. Meanwhile, in the Soviet Union, genetics and the early “positive eugenics” were themselves subject to academic exclusion and a target for political repression.Footnote 72 Officials stigmatized geneticists as supporters of racism and Nazism, nicknaming them “flylovers-humanhaters.” It may be one of the reasons why appeals to exclusively free regulation of genome editing have not met with serious opposition. For instance, Russian biotechnologist Denis Rebrikov dared to publicly propose a program of experimental human genome editing after the He Jiankui case had gathered negative ethical and legal appraisals.Footnote 73

Although the mechanisms of exclusion’s impact on exceptionalism remain a subject of debate, we need not emphasize just the correlation between them but also the substantive relationship between prior exclusion and subsequent exceptionalism. In a nutshell, the facts on who was previously excluded and how they were excluded shape contemporary exceptionalism.

Conclusions

Given the origins and evolution of the notions of exceptionalism, exception, and exclusion, it is understandable that they are closely connected in bioethics, just like in law theory, philosophy, or political theory. Still, each notion has its meaning and scope. Exceptionalism pertains to phenomena that are not (yet) entirely familiar to us and could bear significant risks regarding their regulation. Among these risks is the exclusion of information or specific social groups, as we have demonstrated in several historical examples. In turn, exceptions are helpful in the formulation of detailed regulatory policies and procedures.

From this perspective, the development of the debates on genetic exceptionalism can be described as a movement from awareness of social exclusion through genetic exceptionalism to the set of particular regulatory exceptions. We consider this pattern to be rather common for the evolution of bioethical regulation in an emerging biomedical field.

In the early stage of debates on the regulation of genetic testing, the parties argued about the special status of genetic information. If genetic information is exceptional compared to other medical data, then special regulation is required to prevent a resurgence of eugenic discrimination.Footnote 74 Although genetic information often plays an essential role in family, social, and work stigma and exclusion, it does not necessarily contribute to these phenomena.Footnote 75 Over the decades of the evolution of medical genetics, bioethicists have realized that genetic information does not play a privileged role in exclusion. Ethical and social implications of genetic tests vary from case to case. For these reasons, a more nuanced approach to framing the problem has been adopted. It dealt with the effects of particular genetic tests on various forms of stigma and exclusion.Footnote 76 Particular genetic tests could amplify existing modes of exclusion and assemble new ones based on previously common ones. In fact, this approach has proven to be the most productive in the development of bioethical regulation. Debates about the uniqueness of genetic information have rather been dominated by the development of this nuanced approach than resolved by advances in biological knowledge and medical technology.

Looking at the bigger picture, one can conclude that the lack of a systematic understanding and analysis of the role of exceptionality and exceptions in the development of various bioethical approaches stems from the absence of a bioethical theory of noveltyFootnote 77 which would use a limited number of clearly defined instruments to describe entities that are partially or entirely new for an existing paradigm. While it is impossible to construct such a theory within the framework of a single paper, we believe that we have taken a step in this direction by studying the notions of exceptionality, exception, and exclusion that can potentially form its foundation.

Conflict of Interest

The author declares none.

References

Notes

1. Fox, RC, Swazey, JPObserving Bioethics. Oxford: Oxford University Press; 2008 CrossRefGoogle Scholar.

2. Agar, N. Liberal eugenics. In: Kuhse, H, Singer, P, eds. Bioethics. Oxford: Blackwell; 1999:171–81Google Scholar.

3. Bayer, R. Public health policy and the AIDS epidemic: an end to HIV exceptionalism? The New England Journal of Medicine 1991;324:1500–4CrossRefGoogle ScholarPubMed.

4. Gostin, LO, Hodge, JG Jr. Genetic privacy and the law: an end to genetics exceptionalismJurimetrics 1999 Fall:2158 Google Scholar.

5. Schick, A. Neuro exceptionalism? The American Journal of Bioethics 2005;5(2):36–8CrossRefGoogle Scholar.

6. Wynia, MK. Routine screening: informed consent, stigma and the waning of HIV exceptionalismThe American Journal of Bioethics 2006;6(4):58 CrossRefGoogle ScholarPubMed.

7. Wilson, J, Hunter, D. Research exceptionalismThe American Journal of Bioethics 2010;10(8):4554 CrossRefGoogle ScholarPubMed.

8. Giordano, S. Anorexia nervosa: a case for exceptionalism in ethical decision makingPhilosophy, Psychiatry, & Psychology 2019;26(4):315–31CrossRefGoogle Scholar.

9. Horn, R. The ‘French exception’: the right to continuous deep sedation at the end of lifeJournal of medical ethics 2018;44(3):204–5CrossRefGoogle ScholarPubMed.

10. Gilbar, R, Foster, C. It’s arrived! Relational autonomy comes to court: ABC v ST George’s Healthcare NHS Trust [2017] EWCA 336Medical Law Review 2018;26(1):125–33CrossRefGoogle Scholar.

11. Wilson, J, Hunter, D. Research exceptionalismThe American Journal of Bioethics 2010;10(8):4554 CrossRefGoogle ScholarPubMed.

12. See note 11, Wilson, Hunter 2010, at 45–54.

13. Blain, M, Wallace, SE, Tuegel, C. Shadow of HIV exceptionalism 40 years laterJournal of Medical Ethics 2021;47(11):727–8CrossRefGoogle ScholarPubMed.

14. Tovino, SA. Functional neuroimaging information: A case for neuro exceptionalismFlorida State University Law Review 2006;34:415 Google Scholar.

15. Carlson, RV, Boyd, KM, Webb, DJ. The revision of the Declaration of Helsinki: past, present and futureBritish Journal of Clinical Pharmacology 2004;57(6):695713 CrossRefGoogle ScholarPubMed.

16. Levine, RJ. The need to revise the Declaration of HelsinkiNew England Journal of Medicine 1999;341(7):531–4CrossRefGoogle ScholarPubMed.

17. Munthe, C, Nijsingh, N. Cutting red tape to manage public health threats: An ethical dilemma of expediting antibiotic drug innovation. Bioethics 2019;33(7):785–91CrossRefGoogle ScholarPubMed.

18. Largent, EA, Lynch, HF. Paying research participants: regulatory uncertainty, conceptual confusion, and a path forward. Yale Journal of Health Policy, Law, and Ethics 2017;17(1):61 Google Scholar.

19. Grimwade, O, Savulescu, J, Giubilini, A, Oakley, J, Osowicki, J, Pollard, AJ, Nussberger, AM. Payment in challenge studies: ethics, attitudes and a new payment for risk model. Journal of Medical Ethics 2020;46(12):815–26CrossRefGoogle Scholar.

20. More on these debates in Zammito, J. Kant, Herder, and the Birth of Anthropology. Chicago: University of Chicago Press; 2002 Google Scholar.

21. The roots of Tocqueville’s concept of American exceptionalism can be found, among others, in Fichte’s ideology of German exceptionalism, although Fichte (like Herder and Kant before him) does not use the notion directly. For more on Fichte’s view of the German nation, see Breazale, D, Rockmore, T, eds. Fichte’s Address to the German Nation Reconsidered. New York: SUNY Press; 2016 CrossRefGoogle Scholar. Some scholars even claim that Fichte’s nationalism had striking similarities to Hitler’s ideology of National Socialism (see Ryback T. Hitler’s Private Library. New York: A.A. Knopf; 2008).

22. Poole, T. Constitutional exceptionalism and the common law. International Journal of Constitutional Law 2009;7(2):247–74CrossRefGoogle Scholar.

23. Reitz, KR, ed. American Exceptionalism in Crime and Punishment. Oxford: Oxford University Press; 2017 CrossRefGoogle Scholar.

24. Evans, JP. Genetic exceptionalism: Too much of a good thing? Genetics in Medicine 2008;10:500–1CrossRefGoogle ScholarPubMed.

25. Brown, LD. Exceptionalism as the rule? U.S. health policy innovation and cross-national learning. Journal of Health Politics, Policy and Law 1998;23(1):3551 CrossRefGoogle ScholarPubMed. Here, and in the debates on “criminal law exceptionalism” in the USA, we can see specific examples of how the notion of American exceptionalism was successfully adapted to debates outside of political theory.

26. See several examples in part III.

27. See, for instance, Mills, C. Exception. In: Bevir, M, ed., Encyclopedia of Political Theory. Thousand Oaks: SAGE Publications; 2010:469–70Google Scholar.

28. See lib. IV, tit. XIII: De exceptionibus.

29. In his Méditation sur la notion commune de la justice (presumably 1702), Leibniz states that we need exceptions from a strict rule (jus strictum), linking the exception with the idea of equality (equitas) and piety (pietas). Strict adherence to the strict rule without regard for equity could only lead to lawlessness, and so in justified cases, we have to make an exception from it in order to mitigate it.

30. For instance, Kant argues that people are inclined to consider themselves as an exception to any rule and, at the same time, to assume that others should not and will not do so ( Kant, I. Groundwork of the Metaphysics of Morals. A German-English Edition. Cambridge: Cambridge University Press; 2011: 34, 76Google Scholar), as he points out the role of the categorical imperative in opposing this antimoral tendency which deprives ethical maxims of all their meaning.

31. In Western philosophy, a vast palette of possible uses for this notion is provided in Nietzsche’s works.

32. See, for instance, on exceptions to informed consent of the patients: Crutchfield, P, Gibb, TS, Redinger, MJ. Placebos and a New Exception to Informed Consent. AJOB Neuroscience 2018;9/3:200–2CrossRefGoogle Scholar.

33. A prominent example still retaining its significance in contemporary legal practice is the principle “expressio unius est exclusio alterius” (“the expression of one thing is the exclusion of another”), mentioned in Sir Edward Coke’s Commentary on Littleton (210a), which is the first part of his famous Institutes of the Lawes of England.

34. See Cole, P. Philosophy of exclusion: Liberal political theory and immigration. Edinburgh: Edinburgh University Press; 2020 CrossRefGoogle Scholar.

35. See Garland-Thompson, R. Disability bioethics: From theory to practice. Kennedy Institute of Ethics Journal 2017;27(2):323–39CrossRefGoogle Scholar.

36. See, for instance, Cameron, A. Geographies of welfare and exclusion: social inclusion and exception. Progress in Human Geography 2006;30(3):396404 CrossRefGoogle Scholar, or Thobani, S. Exception as Rule: Profile of Exclusion. Signs: Journal of Women in Culture and Society 2004;29(2):597600 CrossRefGoogle Scholar, or van Natta, M. Medical Legal Violence: Health Care and Immigration Enforcement Against Latinx Noncitizens. New York: NYI Press; 2023 CrossRefGoogle Scholar.

37. Ross, LF. Genetic exceptionalism vs. paradigm shift: lessons from HIV. The Journal of Law, Medicine & Ethics 2001;29(2):141–8CrossRefGoogle ScholarPubMed.

38. Mcgee, G. Foreword: Genetic exceptionalism (symposium: Privacy, property & family in the age of genetic testing). Harvard Journal of Law & Technology 1998;11(3):570 Google Scholar.

39. Mannette, R. Navigating a world of genes: A conceptual analysis of gene fetishism, geneticization, genetic exceptionalism and genetic essentialismEuropean Journal of Medical Genetics 2021;64(8):104232CrossRefGoogle Scholar.

40. Lazzarini, Z. What lessons can we learn from the exceptionalism debate (finally)? Journal of Law, Medicine & Ethics 2001;29(2):149–51CrossRefGoogle ScholarPubMed.

41. Bayer, R. Clinical progress and the future of HIV exceptionalism. Archives of Medicine 1999;159:1042–8Google ScholarPubMed, at 1042.

42. Illes, J, Racine, E. Imaging or imagining? A neuroethics challenge informed by genetics. The American Journal of Bioethics 2005;5(2):518 CrossRefGoogle ScholarPubMed.

43. Wilfond, BS, Ravitsky, V. On the proliferation of bioethics sub-disciplines: do we really need “genethics” and “neuroethics”? The American Journal of Bioethics 2005;5(2):20–1CrossRefGoogle ScholarPubMed.

44. Knoppers, BM. Neuroethics, new ethics? The American Journal of Bioethics 2005;5(2):33 CrossRefGoogle ScholarPubMed.

45. Illes, J, Lombera, S, Rosenberg, J, Arnow, B. In the mind’s eye: provider and patient attitudes on functional brain imagingJournal of Psychiatric Research 2008;43(2):107–14CrossRefGoogle ScholarPubMed.

46. Task Force Report: Genetic Information and Insurance. Bethesda, Maryland: Genetic Information and Health Insurance, National Institutes of Health, National Center for Human Genome Research; 1993.

47. Gostin, LO, Hodge, JG Jr. Genetic Privacy and the Law: An End to Genetics Exceptionalism. Jurimetrics 1999;40:2158 Google Scholar.

48. Murray, TH. Genetic Exceptionalism and ‘Future Diaries’: Is Genetic Information Different from Other Medical Information? In: Rothstein, MA, ed. Genetic Secrets: Protecting Privacy and Confidentialityin the GeneticEra. New Haven: Yale University Press; 1997:6073 Google Scholar. In his answer to Garrison et al., Murray revisited his arguments: Murray, TH. Is Genetic Exceptionalism Past Its Sell-By Date? On Genomic Diaries, Context, and Content. The American Journal of Bioethics 2019;19(1):1315 CrossRefGoogle ScholarPubMed.

49. Green, MJ, Botkin, JR. Genetic exceptionalism in medicine: clarifying the differences between genetic and nongenetic testsAnnals of internal medicine 2003;138(7):571–5CrossRefGoogle Scholar.

50. Garrison, NA, Brothers, KB, Goldenberg, AJ, Lynch, JA. Genomic contextualism: shifting the rhetoric of genetic exceptionalismThe American Journal of Bioethics 2019;19(1):5163 CrossRefGoogle ScholarPubMed.

51. Pugh, J. Genetic exceptionalism, revisionism, pluralism and convergence in the ethics of insurance: response to commentators. Journal of Medical Ethics 2022;48(11):879–80CrossRefGoogle ScholarPubMed.

52. Nill, A, Laczniak, G, Thistle, P. The use of genetic testing information in the insurance industry: an ethical and societal analysis of public policy optionsJournal of Business Ethics 2019;156:105–21CrossRefGoogle Scholar.

53. Zuckerman, S. The emergence of the “genetic counseling” profession as a counteraction to past eugenic concepts and practicesBioethics 2021;35(6):528–39CrossRefGoogle ScholarPubMed.

54. Jonsen, ARThe birth of bioethics. Oxford: Oxford University Press; 2003:175 Google Scholar.

55. Ramsey, P. Fabricated man: The ethics of genetic control. New Haven: Yale University Press; 1970 Google Scholar.

56. See note 54, Jonsen 2003, at 179.

57. Lappé, M, Gustafson, JM, Roblin, R. Ethical and social issues in screening for genetic diseaseNew England Journal of Medicine 1972;286(21):1129–32CrossRefGoogle Scholar.

58. Lappé M. From cloning to genome: human genome. Paper read at the Birth of Bioethics Conference, Seattle, Wa., Sept. 23–24, 1992. Transcript:286–9.

59. See note 57, Lappé et al. 1972, at 1130.

60. See note 63, Lappé et al. 1972, at 1132.

61. See note 54, Jonsen 2003, at 181.

62. See note 57, Lappé et al. 1972, at 1131.

63. We could grasp exceptionalism also as an instrument of “boundary work” in the bioethical domain that, for instance, allowed neuroethics to become a separate field. However, regardless of the extent to which exceptionalism plays the role of a tool for (sub)disciplinary separation, it continues to play its role by providing a venue for reflecting on the ethical and social meaning of new biomedical technology (see Racine, E, Sample, M. Two problematic foundations of neuroethics and pragmatist reconstructions. Cambridge Quarterly of Healthcare Ethics 2018;27(4):566–77CrossRefGoogle ScholarPubMed).

64. Schicktanz, S, Michl, S, Stoff, H. Bioethics and the argumentative legacy of atrocities in medical history: Reflections on a complex relationship. Bioethics 2021;35(6):499507 CrossRefGoogle ScholarPubMed.

65. Ginoza, ME, Isasi, R. Regulating preimplantation genetic testing across the world: a comparison of international policy and ethical perspectives. Cold Spring Harbor Perspectives in Medicine 2020;10(5):a036681 CrossRefGoogle ScholarPubMed.

66. Arzheimer, K. Secular citizens, pious MPs: why German attitudes about genetic testing are much more permissive than German laws. Political Research Exchange 2020;2(1):1765693 CrossRefGoogle Scholar.

67. What the format of this semantic work is, in itself, is another interesting topic to explore. Schicktanz et al. examine it at the micro level of particular arguments (see note 64). Jeffrey Alexander reflects at the macro level on how Nazi crimes constituted a cultural trauma years after the Nürnberg Court (see Alexander, JC. Trauma: A Social Theory. Cambridge: Polity Press; 2012 Google Scholar).

68. Gottweis, H. Stem cell policies in the United States and in Germany: Between bioethics and regulation. Policy Studies Journal 2002;30(4):444–69CrossRefGoogle Scholar.

69. Braun, K. From ethical exceptionalism to ethical exceptions: the rule and exception model and the changing meaning of ethics in german bioregulation. Developing World Bioethics 2017;17(3):146–56CrossRefGoogle ScholarPubMed.

70. Metzler, I. Human life between biology and law in Germany. In: Prozorov, S , Rentea, S, eds. The Routledge Handbook of Biopolitics. London: Routledge; 2016:295313 CrossRefGoogle Scholar.

71. Parfenchyk, V, Flos, A. Human dignity in a comparative perspective: embryo protection regimes in Italy and Germany. Law, Innovation and Technology 2017;9(1):4577 CrossRefGoogle Scholar.

72. Lewontin, R, Levins, R. The problem of Lysenkoism. In: The Radicalisation of Science: Ideology of/in the Natural Sciences. London: Macmillan; 1976:3264 CrossRefGoogle Scholar.

73. Cyranoski, D. Russian biologist plans more CRISPR-edited babies. Nature 2019;570(7760):145–7CrossRefGoogle ScholarPubMed.

74. Garrison, NA, Brothers, KB, Goldenberg, AJ, Lynch, JA. Genomic contextualism: shifting the rhetoric of genetic exceptionalismThe American Journal of Bioethics 2019;19(1):5163 CrossRefGoogle ScholarPubMed.

75. Faure, MC, Matshabane, OP, Marshall, P, Appelbaum, PS, Stein, DJ, Engel, ME, de Vries, J. Does genetics matter for disease-related stigma? The impact of genetic attribution on stigma associated with rheumatic heart disease in the Western Cape, South AfricaSocial Science & Medicine 2019;243:112619 CrossRefGoogle ScholarPubMed.

76. Green, MJ, Botkin, JR. Genetic exceptionalism in medicine: clarifying the differences between genetic and nongenetic testsAnnals of internal medicine 2003;138(7):571–5CrossRefGoogle Scholar.

77. We can find crucial studies on the history of the debates on originality and novelty in science and philosophy (see North, M. Novelty: A History of the New. Chicago: University of Chicago Press; 2013 Google Scholar) and countless papers on the topic of novelty in science that are mainly focused on how we can judge whether a particular phenomenon is novel or not. Still, there is yet to be a general theory that would provide a clear basis for empirically oriented and detailed strategies for handling new phenomena in various sciences.